Skip to Content

Understanding the Shift in Migraine Therapies Over Time

From the early disorganized approach to the now CGRP targeting monocled antibodies, Piero Barbanti, an associate professor of neurology and president of the Italian Headache Sufferers Association, takes us through the eras of treating migraines.

Piero Barbanti

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top